The Post-Pandemic Supply Chain: Improving Resilience Via Value Chains
By Andrew Goldman, Head of Business Continuity Management, Lynn Stephenson, PhD., Senior Marketing Manager, Supply Security, and Oliver Prince, PhD., Senior Consultant, Strategy Optimization
![GettyImages-1331571740-supply-chain-sourcing-logistics-tracking GettyImages-1331571740-supply-chain-sourcing-logistics-tracking](https://vertassets.blob.core.windows.net/image/6b1376cc/6b1376cc-25d3-49b9-861e-866be9462f82/375_250-gettyimages_1331571740_supply_chain_sourcing_logistics_tracking.jpg)
The COVID-19 pandemic underscored the vulnerability of global supply chains, revealing the fragility of lean manufacturing techniques and ‘just-in-time’ inventory models. The strain of supply chain disruptions particularly impacted the pharmaceutical industry as it raced to eradicate the virus. Post-pandemic, supply chain resilience is top of mind. The industry is striving to fortify against future supply chain disruptions by developing a robust plan for the unexpected, involving stronger risk management and focus on the value of customers. The emphasis on value chains over supply chains, driven by customer-centric approaches, marks a transformative post-pandemic shift.
Strengthening the resilience of biopharmaceutical supply chains is not merely a business imperative, for patients around the world are relying on the timely delivery of life-changing and life-saving treatments. In this article, you will explore lessons learned from the pandemic, the concept of supply chain resilience, what to look for in a supplier, and much more.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.